NeoGenomics, Inc. (NEO) vs Neurogene Inc. (NGNE)
A side-by-side comparison of NeoGenomics, Inc. and Neurogene Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEO
NeoGenomics, Inc.
$16.78HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
NGNE
Neurogene Inc.
$25.82HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — NEO vs NGNE
growth of $100 · dividends reinvested · last 10yNEO +134.5% (+8.9%/yr)NGNE -90.1% (-20.6%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
NEO NGNE
NEO vs NGNE: by the numbers
- •NEO is the larger company ($431M vs $408M market cap).
- •Both run net losses; NGNE's is the smaller (0.00% vs -6.77% net margin).
Metrics side by side
Valuation
| Metric | NEO | NGNE |
|---|---|---|
| Forward P/E | 91.83 | N/A |
| P/S ratio | 0.56 | N/A |
| P/B ratio | 0.55 | 1.88 |
Profitability
| Metric | NEO | NGNE |
|---|---|---|
| Gross margin | 42.92% | 0.00% |
| Operating margin | -8.63% | 0.00% |
| Net margin | -6.77% | 0.00% |
| ROE | -6.60% | -51.17% |
| ROIC | -5.29% | -54.45% |
Growth (annualized)
| Metric | NEO | NGNE |
|---|---|---|
| Revenue CAGR (5Y) | 9.41% | N/A |
| Total return CAGR (5Y) | -15.14% | -27.73% |
Frequently asked
- How have NEO and NGNE total returns compared?
- Over the past 10 years, NEO delivered 8.90% and NGNE delivered -21.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.